In a research, scientists pointed out a diminished immune response to Covid-19 vaccines among organ transplant recipients and others on immunosuppressive drug regimes. This presents challenges at both individual and population levels, since current protocols may not provide adequate protection to patients who could, in turn, become reservoirs for new and dangerous variants of the virus.